Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
729 hari yang lalu
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
995 hari yang lalu
Canadian Market Modestly Lower In Cautious Trade
After moving modestly higher in early trades, the Canadian market gave up gains as investors digested the nation's inflation data, and closely followed the developments on Russia-Ukraine peace talks front.
RTTNews
|
2j 1min yang lalu
Swiss Market Ends On Strong Note
After a somewhat subdued start, the Switzerland market gained in strength as the session progressed on Tuesday, to eventually closed on a bright note.
RTTNews
|
2j 41min yang lalu
European Stocks Close Higher On Russia-Ukraine Peace Deal Hopes
European stocks closed higher on Tuesday as the mood remained positive amid optimism over a potential Russia-Ukraine peace deal, after U.S. President Donald Trump described his meeting with Ukrainian President Volodymyr Zelenskyy and several other European leaders as "very good".
RTTNews
|
3j 5min yang lalu
U.S. Housing Starts Unexpectedly Surge In July But Building Permits Slump
A report released by the Commerce Department on Tuesday unexpectedly showed a sharp increase by new residential construction in the U.S. in the month of July. The Commerce Department said housing starts shot up by 5.2 percent to an annual rate of 1.428 million in July after spiking by 5.9 percent to an upwardly revised rate of 1.358 million in June.
RTTNews
|
6j 43min yang lalu
U.S. Housing Starts Unexpectedly Surge 5.2% In July
A report released by the Commerce Department on Tuesday unexpectedly showed a sharp increase by new residential construction in the U.S. in the month of July.
RTTNews
|
7j 45min yang lalu
Swiss Franc Rises Despite Russia-Ukraine Peace Deal Hopes
The safe-haven Swiss franc strengthened against other major currencies in the European session on Tuesday, despite expectations for a peace agreement between Russia and Ukraine.
RTTNews
|
8j 12min yang lalu
